Datapharm is Australia’s original independent full-service Contract Research Organisation (CRO), est. 1987, providing clinical trial management, design, site set-up, monitoring, statistical services, data management (including eCRFs), medical writing, pharmacovigilance and auditing.
Datapharm has earned an enviable reputation for quality, following involvement in hundreds of clinical trials in over 35 therapeutic areas, Phases I (including first-in-human) to IV, for Big Pharma, Biotech, Medical Device companies and Non-profit organisations.
Datapharm works to ICH GCP and international regulatory authority standards with an overlay of excellent project management to achieve project milestones.
Datapharm offers services internationally through the global CRO consortium DAI-SYS.
Novotech is internationally recognized as a leading regional full-service contract research organization (CRO). Novotech has been instrumental in the success of hundreds of Phase I - IV clinical trials in the Asia Pacific region. Novotech provides clinical development services across all clinical trial phases and therapeutic areas including: feasibility assessments; ethics committee and regulatory submissions, data management, statistical analysis, medical monitoring, safety solutions, central lab services, report write-up to ICH requirements, project and vendor management. Novotech’s strong Asia Pacific presence includes running clinical trials in all key regional markets. Novotech also has worldwide reach through the company's network of strategic partners.
TetraQ is a NATA accredited integrated drug development Contract Research Organisation (CRO) that offers a broad range of high quality tailored services (ADME, Bioanalysis, Efficacy, Toxicology, Pharmaceutics) globally to the biotechnology and pharmaceutical industries. Our NATA ISO 17025 (R&D) accreditation and GLP recognition allows our ADME, bioanalytical and Toxicology work to be accepted internationally for regulatory review. TetraQ undergoes regular audits by different authorities.
Its bio-analytical lab supports preclinical and clinical studies. TetraQ has a track record in developing new methods and has >150 validated analytical methods available.
Pain is one of TetraQ’s areas of special expertise. TetraQ has experience with a number of pain target classes, molecule classes, dosing routes and has the ability to quantitatively assess several side effects in many novel vivo models.
At Argenta we've been dedicated to animal health from day one. Since 2006, we've been a trusted partner to clients who need our expertise, partnership and no-challenge-too-tough attitude to bringing innovative new animal health products to market.
Because we are the only global CRO and CMO specializing in animal health, we are uniquely able to offer clients of all sizes a comprehensive product development solution from Molecule to Market, at any scale.
The day-to-day ethos that drives our company forward is a mission focused on global partnerships, a Molecule to Market approach, and of course, innovation.
At the core of our business and our organisation is collaboration — among our global team and with our customers. Working together, we continually challenge ourselves and each other to continue to innovate to develop the best animal health technologies and products possible.
From animal scientists to veterinarians to engineers and other industry experts, our 450+ strong global team is a passionate and diverse group united in their commitment to healthy animals.
We operate from Research & Development locations in New Zealand and the US and (EMA and FDA) GMP approved Manufacturing sites in New Zealand, the United Kingdom (Scotland) and the United States (Fort Dodge, Iowa).
Our company was founded in New Zealand by Doug Cleverly, a scientist who naturally felt more at home in the lab solving problems than in the boardroom. Doug imbued the company with the spirit of Kiwi ingenuity and a global perspective. He saw a need in the market for an animal health company that could provide the highest quality services to customers of all sizes, all over the world. To this day, we are still dedicated to animal health and our founder's legacy of problem solving and inventiveness lives on within the organisation.
Our four clinical research sites are capable of performing studies from small scale Phase 1b trials to large scale, longer term Phase 3 studies. Since 2001 we have been trusted to perform over 120 clinical studies on behalf of worldwide pharmaceutical companies, contract research organisations and individual researchers. As a result we have accumulated a large volunteer database for our clinical trials.